MH
Insider
Michael Thomas Henderson
DirectorMichael Thomas Henderson (Director) filed 13 Form 4 reports in the trailing twelve months (0 purchases, 13 sales), most often in Apogee Therapeutics, Inc. (APGE). The largest single filing was $10.6M of APGE (80,000 sh × $132.54, as filed), executed Jun 22.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
13
0 buys · 13 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$36.0M
shares × price, as filed
Last traded
Jul 8
Filed Jul 10
Median ADV $371.2M across their filed names
Open performance→Volume by month
Buys $0
Sells $41.3M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
13 filings
Sector per market data · by filing · past 12 months
Most traded names
APGERecent filings
APGESALE
Apogee Therapeutics, Inc.
View filing →
$1.2M19,045 sh across 2 lots
Exec Feb 11
Filed Feb 13 · 5:30 PM ET APGESALE Apogee Therapeutics, Inc. View filing → $1.6M
19,530 sh across 5 lots
Exec Jan 14
Filed Jan 16 · 5:30 PM ET APGESALE Apogee Therapeutics, Inc. View filing → $1.5M
19,440 sh across 2 lots
Exec Dec 10 2025
Filed Dec 12 2025 · 5:30 PM ET APGESALE Apogee Therapeutics, Inc. View filing → $3.0M
40,000 sh × $75.01
Exec Dec 4 2025
Filed Dec 5 2025 · 5:30 PM ET APGESALE Apogee Therapeutics, Inc. View filing → $1.3M
19,900 sh across 3 lots
Exec Nov 13 2025
Filed Nov 13 2025 · 5:30 PM ET APGESALE Apogee Therapeutics, Inc. View filing → $220K
7,326 sh × $29.98
Exec Mar 5 2025
Filed Mar 7 2025 · 5:30 PM ET APGESALE Apogee Therapeutics, Inc. View filing → $609K
15,000 sh × $40.58
Exec Feb 5 2025
Filed Feb 7 2025 · 5:30 PM ET APGESALE Apogee Therapeutics, Inc. View filing → $733K
15,000 sh across 2 lots
Exec Jan 8 2025
Filed Jan 10 2025 · 5:30 PM ET More filings →